Business Wire

Zynga Opens Pre-Registration for FarmVille 3 Ahead of November 4, 2021 Launch

Share

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment and creator of the popular FarmVille franchise, today announced that it has opened pre-registration for its upcoming title, FarmVille 3. The agriculture-simulation social game will be available at launch on November 4, 2021 on iOS and Android devices worldwide, as well as on M1-equipped Apple laptop and desktop devices. Zynga also released the game’s reveal trailer introducing fan-favorite farmhand Marie, brand new characters and adorable animals, all waiting for players in FarmVille 3.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211006005037/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Zynga Opens Pre-Registration for FarmVille 3 (Graphic: Business Wire)

“Twelve years ago, FarmVille burst onto the gaming scene, creating a loyal following that has drawn over 700 million installs for the FarmVille series worldwide,” said Bernard Kim, President of Publishing at Zynga. “Today, we are thrilled to open pre-registration for FarmVille 3. The game has been uniquely designed to captivate the imagination of the many players who have enjoyed FarmVille over the past decade, as well as the enthusiasm of a new generation of gamers.”

FarmVille 3 will feature over 150 breeds of animals ranging from chickens and cows to exotic new pets such as friendly tigers and fluffy alpacas. Players can adopt, nurture and raise baby animals including lovable chicks, lambs, piglets and many more adorable creatures. For their parenting efforts, players will be rewarded with unique farm items to help them along their journey.

Returning to the franchise is fan-favorite character Marie, who will guide and greet both the FarmVille community and new players looking to set up land for the very first time. Marie will be accompanied by a cast of more than 30 diverse farmhands. Each character will be equipped with handy skills such as baking, fishing, lumberjacking and crafting to help players on their farm-building journey.

The weather is a game changer, too! Come rain or shine, players will be able to check the in-game weather forecast and use it to their advantage to boost the yield of their next harvest or fishing trip.

Players can pre-register now to stay up to date with the latest news on FarmVille 3 and be among the first to be alerted when the game launches on November 4, 2021. In the first two weeks after the full worldwide launch, players who download the game will receive a special starter kit that contains interactive welcome features, such as decorative elements and the ‘Early Bird profile picture’, designed to help players personalize their in-game country homestead.

Players can pre-register to receive more information by visiting www.FarmVille3.com.

To view FarmVille 3’s reveal trailer, please visit: https://www.youtube.com/watch?v=KELeZObZy6M

To view images for FarmVille 3, please visit: https://www.dropbox.com/sh/xsbcjyc1cbrhxxn/AADLPDssg-4qcxwEcrloZNmba?dl=0

For more information visit:
www.FarmVille3.com
Facebook
Instagram
Twitter

About Zynga Inc.

Zynga is a global leader in interactive entertainment with a mission to connect the world through games. With massive global reach in more than 175 countries and regions, Zynga has a diverse portfolio of popular game franchises that have been downloaded more than four billion times on mobile including CSR Racing™, Empires & Puzzles™, Hair Challenge, Harry Potter: Puzzles & Spells, High Heels!, Merge Dragons!™, Merge Magic!™, Queen Bee™, Toon Blast™, Toy Blast™, Words With Friends™ and Zynga Poker™. With Chartboost, a leading mobile advertising and monetization platform, Zynga is an industry-leading next-generation platform with the ability to optimize programmatic advertising and yields at scale. Founded in 2007, Zynga is headquartered in California with locations in North America, Europe and Asia. For more information, visit www.zynga.com or follow Zynga on Twitter, Instagram, Facebook or the Zynga blog.

About FarmVille

Launched on Facebook in 2009, FarmVille spawned a social gaming franchise that has drawn over 700 million installs worldwide across Facebook, web and mobile platforms. Offering players the ability to grow virtual crops and build digital farms together in real-time, FarmVille has entertained its fans in FarmVille 2, FarmVille 2: Country Escape and FarmVille 2: Tropic Escape. FarmVille 3, a game developed by Zynga Helsinki, aims to reinvent the classic farm building genre and showcase the modern mechanics of mobile gaming.

FORWARD-LOOKING STATEMENTS

This message contains forward-looking statements relating to the anticipated launch date and future game events and features. Forward-looking statements often include words such as “will,” “expect,” “plan,” “intend,” and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties and assumptions. Undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements. More information about these risks, uncertainties and assumptions is or will be described in greater detail in our public filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our Investor Relations website at http://investor.zynga.com or the SEC’s web site at www.sec.gov.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Zynga Media Contacts:
Sarah Ross
saross@zynga.com

Linda Chung
lchung@zynga.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye